电视胸腔镜下纤维蛋白胶粘合奈维网治疗难治性气胸

Application of NEOVEIL agglutinated with BFG for treating intractable pneumothorax under VATS

目的探讨在电视胸腔镜下用纤维蛋白胶喷涂粘合奈维网治疗难治性气胸的临床疗效。方法本院2009年2月～2012年3月收治的62例难治性气胸患者分为两组,其中,治疗组32例在电视胸腔镜下应用纤维蛋白胶粘合奈维网治疗。对照组30例为传统开胸手术治疗。结果治疗组32例患者肺均复张,完全复张时间为1～4d。术中出血量由对照组的(112.5±50.7)mL减少至治疗组的(67.4±27.1)mL,留置胸腔闭式引流管时间由对照组的5～16d,平均(9.3±3.0)d缩短至治疗组的2～6d,平均(3.9±1.2)d,术后引流量由对照组的(396.0±121.6)mL减少至治疗组的(188.7±48.9)mL,无术中转开胸。无并发症,随访4～12个月无复发。结论在电视胸腔镜下应用纤维蛋白胶粘合奈维网治疗难治性气胸,操作简便,创伤小,留置胸管及住院时间明显缩短,术中出血量及术后引流量明显减少,临床疗效明显。

Objective To evaluate the clinical efficacy of NEOVEIL agglutinated with biological fibrin glue （BFG） for treating intractable pneumothorax under VATS. Methods Sixty-two cases wtih intractable pneumothorax from February 2009 to March 2012 were selected and divided into two groups, the treatment group （32 cases） were given NEOVEIL agglutinated with BFG under VATS. The control group（30 cases） were given the traditional thoracotomy operation. Resuits The treatment group had lung expansion. The lung expansion time was 1-4 d; the blood loss was reduced from （112.5±50.7）mL in control group to （67.4±27.1）mL in treatment group, the thoracic tube indwelling time was reduced from 5-16 d, average （9.3±3.0） d in control group to 2-6 d, average （3.9±1.2） d in treatment group, so that postopera rive drainage reduced from （396.0±121.6） mL to （188.7±48.9） mL. There was no hemorrhage and other severe complication occurred. No case was recured in the follow up for 4 to 12 months. Conclusion NEOVEIL agglutinated with BFG for treating intractable pneumothorax under VATS has the advanstages such as easy manipulation, small incision and less ward-time, its effects are obvious.